Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Rheumatology and Immunology Unit, Department of Medicine, University of Rome Campus Biomedico, Rome, Italy.
Clin Exp Immunol. 2022 May 13;208(1):95-102. doi: 10.1093/cei/uxac014.
To assess stimulator of interferon genes (STING) pathway in patients with adult-onset Still's disease (AOSD) who were complicated or not by macrophage activation syndrome (MAS), evaluating peripheral blood mononuclear cells (PBMCs), and synovial tissues. The relative mRNA expression of key molecules of the STING pathway (i.e. CGAS, NLRP4, PKDC, STING1, XRCC5, and XRCC6) and interferon (IFN)-γ was assessed in PBMCs obtained from patients with AOSD, who were complicated or not by MAS, and healthy controls (HCs). A bulky RNA sequencing was performed in synovial tissues from two patients with AOSD. Finally, the ability of heavy ferritin subunit (FeH) to induce the expression of NLRP4 was evaluated in cultured macrophages. Twenty patients with AOSD were analysed. Out of them, seven patients were complicated by MAS. Assessing mRNA relative expression in PBMCs, STING1, NLRP4, XRCC6, and IFN-γ were significantly expressed in AOSD than HCs. The mRNA relative expression of CGAS, PKDC, and XRCC5 did not differ between patients and HCs. Furthermore, NLRP4 and IFN-γ resulted to be significantly increased in patients with AOSD complicated by MAS than others. By RNA-sequencing analysis, we observed that Nlrp4 gene was significantly up-regulated in patients with AOSD. Following the stimulation with FeH, an increased expression of NLRP4 was observed in cultured macrophages. In conclusion, an increased expression of some key molecules of STING pathway characterized patients with AOSD. In addition, our results suggested that a hyper-activity of NLRP4 may be observed in patients with MAS. Furthermore, FeH increased the expression of NLRP4 in cultured macrophages.
为了评估干扰素基因刺激物(STING)通路在并发或不并发巨噬细胞活化综合征(MAS)的成年Still 病(AOSD)患者中的作用,我们评估了外周血单核细胞(PBMC)和滑膜组织。从并发或不并发 MAS 的 AOSD 患者及健康对照者(HC)中获得 PBMC,评估 STING 通路的关键分子(即 CGAS、NLRP4、PKDC、STING1、XRCC5 和 XRCC6)和干扰素(IFN)-γ的相对 mRNA 表达。对两名 AOSD 患者的滑膜组织进行了大量 RNA 测序。最后,评估了重铁蛋白亚基(FeH)在培养的巨噬细胞中诱导 NLRP4 表达的能力。分析了 20 名 AOSD 患者,其中 7 名并发 MAS。在 PBMC 中评估 mRNA 相对表达时,STING1、NLRP4、XRCC6 和 IFN-γ在 AOSD 患者中的表达明显高于 HCs。CGAS、PKDC 和 XRCC5 的 mRNA 相对表达在患者和 HCs 之间无差异。此外,并发 MAS 的 AOSD 患者 NLRP4 和 IFN-γ的表达明显高于其他患者。通过 RNA 测序分析,我们观察到 Nlrp4 基因在 AOSD 患者中明显上调。用 FeH 刺激后,培养的巨噬细胞中 NLRP4 的表达增加。总之,STING 通路的一些关键分子的表达增加是 AOSD 患者的特征。此外,我们的结果表明,MAS 患者中可能观察到 NLRP4 的过度活性。此外,FeH 增加了培养的巨噬细胞中 NLRP4 的表达。